In the first of our new ‘A day in the life of’ series, where we sit down and learn more about the brilliant people behind the scenes at Parkside, we sit down with Allison Bullivant, our Head of Outpatients and Quality.
In this article Professor Isaac Manyonda, Consultant Gynaecologist, looks in more detail at HRT and the risk of breast cancer.
It can be argued that 'the big C' - breast cancer - is a major determinant of whether women take hormone replacement therapy (HRT) or not. Yes, breast cancer is the most common cancer among women in the developed world, accounting for 30% of all cancers in these women. And as we approach October, breast cancer awareness month, this fact is ever more pertinent.
In this new blog post coinciding with World IBD Day (19 May), Dr Jamal Hayat, Consultant Gastroenterologist at Parkside, shares some valuable insight on the disease.
